Table 5.
The effect of non-immunosuppressive interventions in the tracheal allograft model
| Dose | Treatment time | Harvest | Luminal | Epithelial | ||||
| Animal | Compound | (mg/kg per day) | (days) | time (days) | occlusion (%) | loss (%) | n | Reference |
| Rat | Control | - | 0–3 | 3 | 3 | 90 | 12 | [27] |
| 0–10 | 10 | 10 | 98 | 10 | ||||
| 0–30 | 30 | 79 | 100 | 14 | ||||
| Aminoguanidine | 400 i.p. | 0–3 | 3 | 10 | 76 | 12 | ||
| 0–10 | 10 | 21 | 96 | 15 | ||||
| 0–30 | 30 | 92 | 100 | 14 | ||||
| L-Arginine | 2.25% in drinking water | 0–3 | 3 | 1 | 53 | 12 | ||
| 0–10 | 10 | 10 | 60 | 15 | ||||
| 0–30 | 30 | 53 | 93 | 12 | ||||
| Rat | Control | - | –1–10 | 10 | 17 | 80 | 10 | [28] |
| –1–30 | 30 | 85 | 100 | 10 | ||||
| CGP 53716 | 50 i.p. | –1–10 | 10 | 6 | 67 | 10 | ||
| –1–30 | 30 | 44 | 100 | 10 | ||||
| Rat | Control | - | 1–21 | 21 | 83 | n.r. | [73] | |
| Losartan | 80 in drinking water | 1–21 | 21 | 83 | ||||
| 5–21 | 21 | 30 | ||||||
| Rat | Control | - | –5–21 | 21 | 83 | 100 | 5 | [48] |
| Captopril | 100 in drinking water | –5–21 | 21 | 45 | 100 | 5 | ||
| 1–21 | 21 | 26 | 100 | 5 | ||||
| 5–21 | 21 | 83 | 100 | 5 |
i.p., intraperitoneally; n.r., not reported.